Samuel Singer, CFA
Sam is the Chief Financial Officer at Totus Medicines, where he is responsible for the financial operations and financial strategy of the company. Prior to Totus, Sam spent over 12 years investing in biotechnology companies at Granahan Investment Management and Mistral Capital with a focus on early development stage companies. Previously, he spent time as an investment analyst at Wellington Management and Loomis Sayles including earlier experience in public accounting.
Sam graduated from Bentley University with Bachelors Degree in Accountancy and a Masters Degree in Finance. He also holds the CFA designation.